Literature Review

The Role of CT in the COVID-19 Pandemic—Top 5 Takeaways

By |2020-04-01T15:41:44-05:00March 30th, 2020|Breathe Easy Blog, Literature Review|

We’d like to start off by expressing our heartfelt gratitude to the men and women in healthcare who are braving this storm, putting themselves and their families at risk for their commitment to the health and well-being of their patients‒ we see you, we support you and we want to

Read More

Literature Review: COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease

By |2020-02-07T11:16:37-06:00January 8th, 2020|Breathe Easy Blog, Literature Review|

New Criteria Incorporates Quantitative CT Imaging in COPD Diagnosis Introduction In case you missed it, the COPDGene® investigators (112 pulmonary leaders) recently proposed a new methodology to diagnose and classify COPD, based on diagnostic information from over 10,000 smokers.  This is big news! Today’s diagnostic methods for COPD have been

Read More
VIDA is a clinical imaging intelligence company. We are accelerating the approval and adoption of lifesaving therapies to patients through our AI-powered digital biomarker solution. With proprietary imaging biomarkers for precise quantitative endpoints and exceptional trial imaging management services, VIDA’s solution is helping biopharma sponsors save millions in drug development costs. VIDA's services are enabled by the VIDA Intelligence Platform, an AI-powered system that streamlines imaging in clinical trials. The cloud platform facilitates high-quality, reliable imaging data from over 1,500 sites around the globe.

855.900.8432
info@vidalung.ai
COPYRIGHT - VIDA Diagnostics Inc.
VIDA holds regulatory clearances for clinical sales of its VIDA Insights and VIDA Discovery solutions in the US and Canada. VIDA is HIPAA compliant.
cera
Go to Top